Escalon Medical Corp.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.7M | $12.0M | $12.0M | $12.2M | $10.7M | $10.5M | $9.4M | $9.6M |
| Cost of Revenue | $7.2M | $6.5M | $6.8M | $6.7M | $6.1M | $6.0M | $5.2M | $5.0M |
| Gross Profit | $5.6M | $5.5M | $5.1M | $5.5M | $4.6M | $4.4M | $4.2M | $4.6M |
| Gross Margin | 43.7% | 45.7% | 43.0% | 45.0% | 43.0% | 42.3% | 44.7% | 48.1% |
| Operating Expenses | ||||||||
| Research & Development | $501.5K | $753.1K | $688.2K | $818.8K | $991.0K | $890.5K | $1.1M | $739.8K |
| SG&A Expense | $5.0M | $4.6M | $4.6M | $4.2M | $4.1M | $3.6M | $3.9M | $4.1M |
| Operating Income | $45.2K | $133.2K | $-104.5K | $478.5K | $-470.1K | $-33.7K | $-1.4M | $-253.0K |
| Operating Margin | 0.4% | 1.1% | -0.9% | 3.9% | -4.4% | -0.3% | -14.9% | -2.6% |
| Interest Expense | — | — | $20.8K | $21.7K | $18.4K | $21.8K | $13.6K | $17.4K |
| Pretax Income | $2.9M | $105.5K | — | — | — | — | — | — |
| Income Tax Expense | $-1.1M | $0 | $0 | $0 | $0 | — | — | — |
| Net Income | $4.0M | $105.5K | $-125.3K | $456.8K | $18.1K | $-52.0K | $-650.3K | $-250.0K |
| Net Margin | 31.5% | 0.9% | -1.0% | 3.8% | 0.2% | -0.5% | -6.9% | -2.6% |
| EPS (Basic) | $0.27 | $0.00 | $-0.02 | $0.03 | $0.00 | $-0.01 | $-0.09 | $-0.04 |
| EPS (Diluted) | $0.27 | $0.00 | $-0.02 | $0.03 | $0.00 | $-0.01 | $-0.09 | $-0.04 |
| Shares Outstanding (Basic) | 7.4M | 7.4M | 7.4M | 7.4M | 7.4M | 7.4M | 7.4M | 7.4M |
| Shares Outstanding (Diluted) | 14.6M | 14.3M | 7.4M | 13.6M | 13.2M | 7.4M | 7.4M | 7.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |